160 related articles for article (PubMed ID: 22338184)
1. [Advances in research on haematopoietic stem cell transplantation-associated thrombotic microangiopathy].
Chen X; Feng SZ
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):560-3. PubMed ID: 22338184
[No Abstract] [Full Text] [Related]
2. Successful treatment of refractory acute GVHD complicated by severe intestinal transplant-associated thrombotic microangiopathy using recombinant thrombomodulin.
Inoue Y; Kosugi S; Miura I; Hatta Y; Takeuchi J
Thromb Res; 2011 Jun; 127(6):603-4. PubMed ID: 21262525
[No Abstract] [Full Text] [Related]
3. Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin.
Sakai M; Ikezoe T; Bandobashi K; Togitani K; Yokoyama A
Bone Marrow Transplant; 2010 Apr; 45(4):803-5. PubMed ID: 19767779
[No Abstract] [Full Text] [Related]
4. Plasmapheresis-refractory thrombotic microangiopathy in a hematopoietic stem cell transplant recipient.
Vasko R; Groenewold F; Korsten P; Müller GA; Koziolek M
Ther Apher Dial; 2011 Oct; 15(5):507-9. PubMed ID: 21974708
[No Abstract] [Full Text] [Related]
5. Transplant-associated thrombotic microangiopathy.
Renaudon-Smith E; De La Fuente J; Bain BJ
Am J Hematol; 2016 Nov; 91(11):1160. PubMed ID: 27348509
[No Abstract] [Full Text] [Related]
6. [Changes in diagnostic criteria of thrombotic microangiopathy after stem cell transplantation].
Horváth O; Prohászka Z; Kállay K; Kassa C; Stréhn A; Csordás K; Sinkó J; Kriván G
Orv Hetil; 2017 Jul; 158(27):1043-1050. PubMed ID: 28670985
[TBL] [Abstract][Full Text] [Related]
7. Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy.
Vasu S; Wu H; Satoskar A; Puto M; Roddy J; Blum W; Klisovic R; Andritsos L; Hofmeister C; Benson DM; Efebera Y; Jaglowski S; Penza S; Cohen D; Devine S; Cataland S
Bone Marrow Transplant; 2016 Sep; 51(9):1241-4. PubMed ID: 27064689
[No Abstract] [Full Text] [Related]
8. Transplant-associated thrombotic microangiopathy: is the treatment more expensive than the disease?
Vaughn JL; Zhao Q; Epperla N; Puto M; Roddy J; Elder P; Blum W; Klisovic R; Jaglowski S; Penza S; William B; Andritsos L; Brammer JE; Hofmeister C; Efebera Y; Benson D; Devine S; Cataland S; Vasu S
Bone Marrow Transplant; 2019 Jun; 54(6):913-916. PubMed ID: 30413812
[No Abstract] [Full Text] [Related]
9. Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation.
Lesesve JF; Alla F; Dugué F; Salignac S; Clément L; Lecompte T; Bordigoni P
Int J Lab Hematol; 2011 Aug; 33(4):343-56. PubMed ID: 21284831
[TBL] [Abstract][Full Text] [Related]
10. A case of transplantation-associated thrombotic microangiopathy with autopsy-proven fatal myocardial ischemia after allogeneic hematopoietic stem cell transplantation.
Sasaki K; Honda A; Shinozaki-Ushiku A; Fujioka Y; Maki H; Toyama K; Ushiku T; Kurokawa M
Ann Hematol; 2021 Jun; 100(6):1621-1622. PubMed ID: 32372148
[No Abstract] [Full Text] [Related]
11. Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning.
Willems E; Baron F; Seidel L; Frère P; Fillet G; Beguin Y
Bone Marrow Transplant; 2010 Apr; 45(4):689-93. PubMed ID: 19718063
[TBL] [Abstract][Full Text] [Related]
12. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.
Cho BS; Yahng SA; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Transplantation; 2010 Oct; 90(8):918-26. PubMed ID: 20717073
[TBL] [Abstract][Full Text] [Related]
13. Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy.
Peffault de Latour R; Xhaard A; Fremeaux-Bacchi V; Coppo P; Fischer AM; Helley D; Socié G
Br J Haematol; 2013 Apr; 161(2):279-80. PubMed ID: 23294015
[No Abstract] [Full Text] [Related]
14. Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy.
Lerner D; Dandoy C; Hirsch R; Laskin B; Davies SM; Jodele S
Bone Marrow Transplant; 2014 Jun; 49(6):862-3. PubMed ID: 24637900
[No Abstract] [Full Text] [Related]
15. Thrombotic microangiopathy in allogeneic stem cell transplantation in childhood.
Erbey F; Bayram I; Kuskonmaz B; Yilmaz S; Cetin M; Uckan D; Tanyeli A
Exp Clin Transplant; 2010 Sep; 8(3):237-44. PubMed ID: 20716043
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of endothelial injury and transplant-associated thrombotic microangiopathy in tandem autologous hematopoietic stem cell transplant for neuroblastoma.
Sabulski A; Abdullah S; Luebbering N; Aunins B; Castillo C; Lake K; Duell A; Strecker L; Langenberg L; Broomhead W; DiMeo S; Odegard EA; Blackard JT; Ziady AG; Seif AE; Dandoy CE; Laskin BL; Jodele S; Davies SM
Haematologica; 2023 Dec; 108(12):3449-3453. PubMed ID: 37317894
[No Abstract] [Full Text] [Related]
17. Thrombotic microangiopathy following haematopoietic stem cell transplant.
Seaby EG; Gilbert RD
Pediatr Nephrol; 2018 Sep; 33(9):1489-1500. PubMed ID: 28993886
[TBL] [Abstract][Full Text] [Related]
18. TMA: beware of complements.
Ricklin D; Cines DB
Blood; 2013 Sep; 122(12):1997-9. PubMed ID: 24052540
[TBL] [Abstract][Full Text] [Related]
19. Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adults.
Alhomoud M; Williams A; Magro C; Van Besien K; Vesole DH; Laurence J
Leuk Lymphoma; 2022 Feb; 63(2):473-477. PubMed ID: 34668824
[No Abstract] [Full Text] [Related]
20. Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.
Kennedy GA; Kearey N; Bleakley S; Butler J; Mudie K; Durrant S
Bone Marrow Transplant; 2010 Apr; 45(4):699-704. PubMed ID: 19767787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
